| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 8
| Issue : 2 | Page : 53-63 |
|
|
Recent changes in guidelines on programmatic management of drug resistant tuberculosis in India 2019: a paradigm shift in tuberculosis control
Arunabha Datta Chaudhuri
Professor, Department of Respiratory Medicine, R.G. Kar Medical College, Kolkata, West Bengal, India
Correspondence Address:
Prof. (Dr.) Arunabha Datta Chaudhuri
Designation - Professor, Department of Respiratory Medicine R.G. Kar Medical College, Kolkata, Residence - BF-130, Sector - I, Salt Lake City, Kolkata - 700064
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jacp.jacp_47_20
|
|
|
The new version of guidelines of programmatic management of drug resistant tuberculosis in India 2019 by Revised National Tuberculosis Control Programme, Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhawan, New Delhi, integrates use of the shorter MDR TB regimen and all oral longer MDR TB regimen with new drugs under RNTCP with opportunity to modify the regimen based on DST results. There are mammoth and comprehensive changes in the guidelines on programmatic management of drug resistant tuberculosis in India 2019.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
